Leading longevity investors by deal count (Longevity Investors Conference)
A top 10 of investors by number of deals in the longevity sector, published on the Longevity Investors Conference blog in July 2025 as part of a longevity investment landscape report. It gives founders a quick list of the most frequent backers of aging-related companies.
- Reliability
- Grade C · 6/12
- Publisher
- Longevity Investors Conference
- Ranks
- Investors, Longevity
- Editions
- 1 since 2025
- Method
- Data
- How items get in
- Compiled by the publisher
- Status
- New
Editions
| Edition | Published | Top of the list | On record |
|---|---|---|---|
| 2025 | July 4, 2025 | GV | 10 |
How the ranking works
Deal counts are cited to Spannr's longevity investor database ('Longevity Investors - Spannr, accessed on June 27, 2025'). The time window is not stated, so counts may be cumulative. Investors of all types are included, including a government funder (NIH). Ranks 5 and 6 (38 deals) and 9 and 10 (25 deals) share counts but are listed with distinct ranks.
Ranked positions: Each item has a position (1, 2, 3), with ties allowed. Investors cannot apply or pay to be ranked; counts are taken from a third-party database (Spannr). The publisher runs an invitation-only investor conference, and its blog post is marketing for that event.
How far to trust it
Superscout grades every ranking on six criteria, each scored 0 to 2. Leading longevity investors by deal count (Longevity Investors Conference) scores 6 of 12, grade C.
- Transparency 1/2
- Source named, but window and sector definition are not.
- Independence 2/2
- No application or fee; publisher has no stated stake in ranks.
- Evidence 1/2
- Secondary compilation of third-party counts.
- Stability 1/2
- Single edition; not assessable.
- Coverage 1/2
- Top 10 only.
- Track record 0/2
- First and only edition.
History
Published July 4, 2025 on the Longevity Investors Conference blog (the Gstaad conference organizer) and promoted on LinkedIn ahead of the September 2025 conference. No earlier or later edition was found.
How it is received
No external commentary was found. The report is a secondary compilation of third-party data rather than original research, and the sector definition of 'longevity' follows the data provider.
Strengths
- Short, specific list for a niche sector.
- States its data source and access date.
- Free to read.
- Shows deal counts for each firm.
Weaknesses
- Time window of the deal counts is not stated.
- Relies entirely on a third-party database with its own sector definition.
- Mixes VC firms with a government funder (NIH).
- Single edition; published as conference marketing content.
Open questions
Facts not verified yet. They stay visible so they are not mistaken for settled facts.
- Window of the deal counts (all-time or recent years) is not stated.
- Whether the list will be updated for the 2026 conference is unknown.
- The blog index snippet showed an unrelated date (Nov 7, 2023); the post page gives July 4, 2025, which is used.
Superscout describes Leading longevity investors by deal count (Longevity Investors Conference) independently from the publisher’s own pages and outside coverage, linked below. The rankings belong to Longevity Investors Conference.